MedPath

AIRLUKAST TABLETS 10 mg

Registration Number: MAL11085001AZ

Approved
Approval ID

52734e84b5d41a08

Registration Number

MAL11085001AZ

Registration Date

Jul 7, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types3 types
Last UpdatedJul 7, 2025

PACKAGING INFORMATION (3)

3x10tablet TabletsAvailable
Package Size: 3x10tablet Tablets
Status: NPRA Approved
6x10tablet TabletsAvailable
Package Size: 6x10tablet Tablets
Status: NPRA Approved
10x10tablet TabletsAvailable
Package Size: 10x10tablet Tablets
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (1)

MONTELUKAST SODIUMActive
Monograph: 孟鲁司特钠

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

AIRLUKAST TABLETS 10 mg - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform